BURGESS MICHAEL F. (Head of Research & Development) received a stock award from SPRINGWORKS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/10/2022ACC: 0001104659-22-002741
Officer· Head of Research & Development
Since May 2021
+64.53K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
64.53K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+15.67K
Price / share
—
Trade value
—
% of position
57.0%
1/6/2022
27.50K→43.17K
Total
Net shares
+15.67K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/6/2022 | A · Award | +15.67K | — | — | 57.0% | 27.50K | 43.17K |
| Total | +15.67K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
48.85K shares
Shares
+48.85K
Strike price
59.46
Held after
48.85K
Exercisable
—
1/6/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock48.85K shares | 1/6/2022 | A · Award | +48.85K | 59.46 | — | 48.85K |